Major Rating Factors:
Poor long-term capitalization index (0.5 on a scale of 0 to 10) based on weak current risk adjusted capital (severe and moderate loss scenarios). Weak overall results on stability tests (2.2) including weak results on operational trends, negative cash flow from operations for 2024 and excessive premium growth. The largest net exposure for one risk is high at 3.1% of capital. Fair reserve development (4.3) as the level of reserves has at times been insufficient to cover claims. In 2023 and 2022 the two year reserve development was 17.5% and 35.1% deficient respectively.
Other Rating Factors:
Fair profitability index (4.6) with operating losses during 2021 and 2023. Superior liquidity (10.0) with ample operational cash flow and liquid investments.
Stability Factors:
C - Past results on our Risk-Adjusted Capital tests.
D - Limited diversification of general business, policy, and/or investment risk.
F - Negative cash flow.
T - Significant trends in critical asset, liability, income or expense items.
Principal Lines of Business:
Med mal (99.6%), other (0.4%)
Licensed in:
DC
Principal Investments:
Cash (100.0%)
Ratios
Premium to Surplus
Reserve to Surplus
1-Year Reserve Development
2-Year Reserve Development
Expense Ratio
Combined Ratio
Cash From Underwriting
Net Premium Growth
Investments in Affiliates
--
Corporate Info
Group Affiliation
COPIC Trust
Investment Rating
--
Company Address
7351 East Lowry Boulevard
Denver, CO 80230
Denver, CO 80230
Phone Number
(720) 858-6000
NAIC Number
14906
Largest Affiliates